NEW YORK ( TheStreet) -- CHANGE IN RATINGSAdvance Auto ( AAP) was upgraded at Deutsche Bank to buy from hold. $92 price target. Expectations are low, even though industry trends are improving, Deutsche Bank said. Bed Bath & Beyond ( BBBY) was downgraded at Oppenheimer to hold from buy. Valuation call, based on a $78 price target, Oppenheimer said. Baidu.com ( BIDU) was upgraded at Morgan Stanley to overweight from equal-weight. $144.70 price target. Improved outlook and mobile monetization, Morgan Stanley said. Cerner ( CERN) was downgraded at Robert Baird to neutral from outperform. Risk/reward is more balanced at current levels, Robert Baird said. Campbell Soup ( CPB) was upgraded at Credit Suisse to neutral from underperform. $48 price target. Company has a stronger foundation and can achieve its growth targets, Credit Suisse said. Convergys ( CVG) was downgraded at Citigroup to neutral from buy and given a $21 price target. The turnaround has played out and CVG is more fairly valued, Citi said.
Dupont Fabros ( DFT) was upgraded at Robert Baird to outperform from neutral. $27 price target. Recent weakness in the stock has created a great entry point, Robert Baird said. Diamond Offshore ( DO) was downgraded at Williams Financial to hold from buy. $77 price target. Company is seeing higher downtime and utilization, in addition to higher expenses, Williams said. Emcor ( EME) was downgraded at DA Davidson to neutral from buy. $45 price target. Stock has made a big run, but earnings expectations are coming down, DA Davidson said. Facebook ( FB) was downgraded at Argus Research to hold from buy. Valuation call, as second quarter results are likely not sustainable, Argus said.
Flir Systems ( FLIR) was downgraded at Keybanc to hold from buy. Valuation call, as the stock has enjoyed a big run, Keybanc said. Freescale ( FSL) was downgraded at Oppenheimer to perform from outperform. Upside appears limited, barring an acceleration in the macro recovery, Oppenheimer said. Global Payments ( GPN) was downgraded at UBS to neutral from buy and given a $49 price target. Growth isn't materializing and visibility is limited, UBS said.